Immatics N.V. (IMTX) Stock Forecast

NASDAQ: IMTXAnalyst ratings, price target and estimates.

IMTX analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
5.00 / 5 from 9 analysts
Price target
$17.26
average of analyst targets
Upside to target
+156.4%
from the latest close
Next earnings
November 16, 2026
EPS estimate $-0.49
52-week range
$6.73 – $11.87

IMTX analyst ratings

9 analysts
Strong buy
9100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

IMTX price target

Price $6.73Target $17.26
52-week low $6.7352-week high $11.87

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

IMTX earnings per share estimates

Immatics N.V. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.50−$0.54−$0.44−$0.49−2.7%8
Current fiscal year (2026)−$2.06−$2.35−$1.91−$1.87−9.9%8
Next fiscal year (2027)−$2.03−$2.46−$1.63−$2.06+1.5%8

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

IMTX revenue estimates

Immatics N.V. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$12.5M$7.3M$16.5M+108.0%9
Current fiscal year (2026)$45.7M$29.0M$61.5M−18.5%9
Next fiscal year (2027)$39.7M$0$78.3M−13.1%9

IMTX EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

IMTX revenue: reported and forecast

Reported revenueEstimate (average; low–high)

IMTX EPS estimate revisions

Immatics N.V. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.50−$0.49−$0.50−$0.50−$0.50+0.7%3 up · 4 down
Current fiscal year (2026)−$1.94−$1.90−$2.07−$2.07−$2.06+6.0%2 up · 5 down
Next fiscal year (2027)−$1.90−$1.90−$2.07−$2.07−$2.03+6.6%1 up · 6 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

IMTX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; IMTX beat in 7 of 12.

What analysts expect from IMTX

9 analysts cover Immatics; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $17.26, 156.4% above the latest close of $6.73. Analysts expect earnings of −$2.06 per share for 2026, −9.9% from a year earlier. For 2027 the average estimate is −$2.03 per share on revenue of $39.7 million. Immatics beat the EPS estimate in 7 of the last 12 quarters.

Related: IMTX income statement, IMTX key metrics, IMTX chart. See the IMTX stock overview for the latest quote and news.

IMTX forecast FAQ

What is Immatics's price target?

The average analyst price target for Immatics is $17.26, 156.4% above the latest close of $6.73.

Is Immatics a buy, hold or sell?

Of 9 analysts covering Immatics, 9 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Immatics's EPS forecast?

Analysts forecast −$2.06 per share for 2026 (range −$2.35 to −$1.91); for 2027 the estimate is −$2.03.

What is Immatics's revenue forecast?

The average revenue estimate for 2026 is $45.7 million, growth of −18.5%; for 2027 it is $39.7 million.

When does Immatics report earnings?

Immatics is expected to report results for the quarter ending September 30, 2026 on November 16, 2026; the EPS estimate is $-0.49.

Does Immatics usually beat earnings estimates?

Immatics reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Biotechnology: forecast